Evogene Ltd. (EVGN)
0.3822
-0.02
(-4.09%)
USD |
NASDAQ |
Oct 09, 16:00
0.3907
+0.01
(+2.22%)
Pre-Market: 20:00
Evogene EPS Diluted (Quarterly) : -0.1449 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1449 |
| March 31, 2026 | -0.6028 |
| December 31, 2025 | -0.609 |
| September 30, 2025 | 0.4444 |
| June 30, 2025 | -0.6175 |
| March 31, 2025 | -0.3805 |
| December 31, 2024 | 0.0628 |
| September 30, 2024 | -1.314 |
| June 30, 2024 | -1.064 |
| March 31, 2024 | -0.7631 |
| December 31, 2023 | -1.305 |
| September 30, 2023 | -0.8143 |
| June 30, 2023 | -1.686 |
| March 31, 2023 | -1.512 |
| December 31, 2022 | -0.7271 |
| September 30, 2022 | -1.588 |
| June 30, 2022 | -2.141 |
| March 31, 2022 | -2.009 |
| December 31, 2021 | -1.790 |
| September 30, 2021 | -1.863 |
| June 30, 2021 | -1.530 |
| March 31, 2021 | -1.695 |
| December 31, 2020 | -2.381 |
| September 30, 2020 | -1.774 |
| June 30, 2020 | -1.646 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.418 |
| December 31, 2019 | -2.36 |
| September 30, 2019 | -1.643 |
| June 30, 2019 | -1.590 |
| March 31, 2019 | -1.440 |
| December 31, 2018 | -2.252 |
| September 30, 2018 | -1.864 |
| June 30, 2018 | -1.852 |
| March 31, 2018 | -2.092 |
| December 31, 2017 | -2.40 |
| September 30, 2017 | -2.00 |
| June 30, 2017 | -1.80 |
| March 31, 2017 | -1.90 |
| December 31, 2016 | -2.60 |
| September 30, 2016 | -2.00 |
| June 30, 2016 | -1.80 |
| March 31, 2016 | -1.30 |
| December 31, 2015 | -2.20 |
| September 30, 2015 | -1.30 |
| June 30, 2015 | -1.90 |
| March 31, 2015 | -1.30 |
| December 31, 2014 | -1.90 |
| September 30, 2014 | -1.70 |
| June 30, 2014 | -1.30 |
| March 31, 2014 | -0.94 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.074 |
| Pluri, Inc. | -0.5432 |
| Scinai Immunotherapeutics Ltd. | -3.662 |
| CollPlant Biotechnologies Ltd. | -1.890 |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.591M |
| Revenue (Quarterly) | 0.347M |
| Total Expenses (Quarterly) | 1.939M |
| Enterprise Value | 6.981M |
| Gross Profit Margin (Quarterly) | -2.31% |
| Profit Margin (Quarterly) | -458.5% |
| Earnings Yield | -238.7% |
| Normalized Earnings Yield | -238.67 |